Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
GI Eosinophilic Disorders
•
Primary Care
Do you use asthma or EoE dosing if initiating dupilumab in a patient who meets criteria for treatment for both disorders?
Answer from: at Community Practice
I would do the higher dose (EoE) if starting it for both.
Sign in or Register to read more
23638
Related Questions
How often do you find a food allergy on a skin test in an EoE patient that when avoided will result in significant resolution of EoE?
What patients with food allergies do you screen for EoE?
Have you been able to safely use other bisphosphonates in patients who developed an allergic reaction (angioedema) to fosamax?
How do you discuss the overlap of POTS, Ehlers-Danlos and MCAS with patients?
Can a biopsy finding of eosinophilia in the gut (esophagus, stomach, duodenum) be reactive in the setting of Crohn's disease or due to anti-TNF blockade?
How do you counsel parents about the anticipated abdominal pain associated with oral desensitization in peanut-allergic children?
Would you ever use dupilumab for atopic dermatitis in a patient who also has EGPA?
Do you continue shots when a patient transfers under your care and has been receiving less than effective doses of AIT, but insist they have been effective?
What medications would you have a patient avoid with an IgE mediated reaction to cyclobenzaprine?
Which patient characteristics or scenarios drive you to choose tezepelumab over dupilumab for asthma?